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Abstract 
The UK Biobank (UKB) is a health research resource of major international importance, 
incorporating comprehensive characterisation of over 500,000 men and women recruited between 
2006-2010 from across the UK. There is prospective tracking of health outcomes for all participants 
through linkages with national cohorts (death registers, cancer registers, electronic hospital records, 
primary care records). The dataset has been enhanced with the UKB imaging study, which aims to 
scan a subset of 100,000 participants. The imaging protocol includes magnetic resonance imaging of 
the brain, heart, and abdomen, carotid ultrasound, and whole-body dual x-ray absorptiometry (DXA). 
Since its launch in 2015, over 48,000 participants have completed the imaging study with scheduled 
completion in 2023. Repeat imaging of 10,000 participants has been approved and commenced in 
2019. The cardiovascular magnetic resonance (CMR) scan provides detailed assessment of cardiac 
structure and function comprising bright blood anatomic assessment (sagittal, coronal, axial), left and 
right ventricular cine images (long and short axis), myocardial tagging, native T1 mapping, aortic 
flow, and imaging of the thoracic aorta. The UKB is an open access resource available to health 
researchers across all scientific disciplines from both academia and industry with no preferential 
access or exclusivity. In this paper, we consider how we may best utilise the UKB CMR data to 
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Introduction to the UK Biobank  
The UK Biobank (UKB) comprises a cohort of over 500,000 men and women aged 40-69 years at 
recruitment (2006-2010). Baseline assessment included a comprehensive series of questionnaires, 
face-to-face interviews, physical measures, and blood sampling. The full protocol is publicly 
available1 and summary data may be viewed on the UKB website: www.ukbiobank.ac.uk. Blood 
biomarker (haematology, biochemistry) and whole genome sequencing are available for all 
participants (released 2019). The UKB imaging study was launched in 2015, with the aim of scanning 
20% of the original cohort, that is, 100,000 participants2. The imaging protocol includes magnetic 
resonance imaging of the brain, heart, and abdomen, carotid ultrasound, and whole-body dual x-ray 
absorptiometry (DXA). To date (September 2020), over 48,000 participants have completed the 
imaging study with scheduled completion by the end of 2023. Repeat imaging of 10,000 participants 
commenced in 2019 and is also due for completion in 2023. Selected components of the baseline 
assessment were repeated for a subset of 20,000 participants between 2012-2013 (calibration visit) 
and at both imaging visits, permitting adjustment for random measurement error and estimation of 
longitudinal variations. 
 
Health outcomes for all UKB participants are prospectively tracked through linkages with electronic 
hospital records, cancer registers, death registers, and primary care records. The UKB has also 
produced algorithmically defined outcomes for incidence of key illnesses, such as myocardial 
infarction, through cross-checking over multiple data sources3. The scale of the UKB and the 
indefinite follow up of participants means that there should be sufficient numbers of a wide range of 
incident illnesses for adequately powered nested case-control studies (Table 1)1, and indeed for 
prospective cohort analyses for more common outcomes. The documentation of incident outcomes 
some years after assessment of exposures reduces (although does not remove completely) the chance 
of reverse causation explaining observed associations. In addition, whilst there is, as is usual with 
such cohorts, evidence of healthy selection; there is, for the majority of variables, a substantial range 
of risk factor levels and disease rates within the UKB population, with sufficient variation to allow 
adequately powered analyses, which may be generalisable across a range of demographics4,5.  
 
The UKB is an open access resource available to health researchers across all scientific disciplines 
from both academia and industry with no preferential access or exclusivity. New researchers can find 
details on formal access procedures (including the modest access charges based on a cost recovery 
model) on the UKB website: www.ukbiobank.ac.uk. 
 
Thus, the UKB comprises a very large sample phenotyped in great detail at multiple time-points using 
a variety of methods and linked to prospectively verified health outcomes (Figure 1), available at 
minimal cost to all bona fide researchers globally. The unique combination of this level of breadth, 
depth, and scale in a single dataset makes for a powerful research resource. In this paper, we consider 
how we may best utilise the cardiovascular magnetic resonance (CMR) data in conjunction with all 
the other information in the UKB to advance cardiovascular research and review notable 
achievements to date. 
 
The UK Biobank CMR protocol 
The UKB imaging study is conducted across four UK sites (Reading, Stockport, Newcastle, Bristol) 
using uniform equipment, staff training, and acquisition protocols. The purpose-designed CMR 
protocol consists of a 20-minute scan performed using a 1.5 Tesla scanner (MAGNETOM Aera, 
Syngo Platform VD13A, Siemens Healthcare, Erlangen, Germany). The practical and ethical 
considerations posed by the large scale and observational nature of the UKB preclude the use of 
contrast or stress agents. The rationale, challenges, and details of the CMR protocol are described in 
dedicated publications6,7. The protocol includes bright blood anatomic assessment (sagittal, coronal, 
axial), left and right ventricular cine images (long and short axis), myocardial tagging (three short axis 
slices), native T1 mapping, aortic flow, and imaging of the thoracic aorta (Table 2).  
 
Conventional right and left ventricular (RV, LV) indices such as chamber volumes, ejection fraction, 
and LV mass may be derived from the short axis cine stack. LV end-diastolic volume is an important 
indicator of adverse cardiac remodelling8. Ejection fraction9 and LV mass10 are established prognostic 
markers. Tagging sequences allow measurement of strain, which reflects myocardial contractile 
function at a more granular level compared to conventional indices, such as, ejection fraction11. As 
such, alterations in myocardial strain may be appreciated at earlier or subclinical disease stages12,13. 
Feature tracking techniques using long and short axis cine images are an alternative method of 
deriving measures of myocardial strain. They use block-matching algorithms to estimate myocardial 
motion by marking regions of interest along the myocardial boundaries. Feature tracking does not 
directly label tissue in the same way as tagging, however, post-processing is considerably faster, and 
estimates are adequately reliable for appreciation of associations14. The long axis cine images may 
also be used to obtain measures of atrial size and function, such as left atrial ejection fraction, which 
are reliable predictors of atrial fibrillation in the general population15. This is important, as atrial 
fibrillation is the most common cardiac arrhythmia, particularly in older populations, with significant 
clinical consequences, such as the need for anticoagulation and increased risk of stroke16. Native T1 
mapping allows for myocardial tissue characterisation without the need for contrast administration, 
specifically, identification of areas of fibrosis and/or infarction17. Myocardial fibrosis has been linked 
to a number of cardiac diseases and is a marker of adverse cardiovascular outcomes such as 
ventricular arrhythmias and death18. Infarction reflects underlying ischaemic cardiomyopathy and is 
also linked to increased cardiovascular risk19. Aortic flow sequences permit assessment of aortic valve 
anatomy and function, in particular valvular stenosis. Aortic stenosis is the most common valvular 
pathology in older individuals, with adverse prognostic consequences and potential for alteration of its 
natural history with timely intervention20. Aortic distensibility, a measure of vascular compliance, 
may be derived from transverse cine images of the thoracic aorta through consideration of the relative 
cross-sectional area change of the aorta (aortic strain) per unit pressure21. Aortic distensibility reflects 
aortic bioelastic function with lower distensibility indicating a less compliant aorta and poorer 
vascular health22. There is an inverse association between aortic distensibility and cardiovascular risk, 
specifically, ischaemic heart disease and stroke23. Thus, aortic distensibility provides a continuous 
measure of ischaemic cardiovascular risk across the population. 
 
In summary, the UKB CMR protocol provides a comprehensive assessment of cardiovascular health, 
providing measures of cardiac structure, function, and tissue characterisation alongside multiple 
prognostic indices, biomarkers of subclinical disease, and indicators of important conditions such as 
atrial fibrillation and aortic stenosis. The CMR imaging phenotypes allow objective assessment and 
quantification of exposure effects on cardiovascular health and permit finer delineation of disease 
trajectories with potential for disease-specific assertions.  
 
Manual analysis of the first 5,000 CMR scans 
Manual segmentation of all four cardiac chambers has been completed for the first 5,000 UKB CMR 
scans. Analysis was across two core laboratories (London, Oxford) according to a pre-defined 
protocol in line with international guidance24. The analysis protocol is available in a separate 
publication25. Readers across both sites received dedicated training and standardised quality control 
procedures were implemented. In this way, a 5,000 subject manual analysis ground truth database was 
created. This dataset has been utilised to derive age- and sex-specific CMR normal reference ranges 
for the LV, RV, and atria in the largest reported cohort of validated healthy adults25. The UKB CMR 
dataset has also resulted in a number of significant achievements providing novel insights into 
classical and non-classical cardiovascular risk factors, and enabling development and evaluation of 
novel CMR biomarkers and automated image analysis pipelines (Supplementary Table 1)26. 
 
Novel insights into classical cardiovascular risk factors 
A number of researchers have used the UKB CMR dataset to provide new insights into classical 
cardiovascular risk factors. For instance, Petersen et al.27 define and quantify alterations in cardiac 
structure and function associated with known modifiable cardiovascular risk factors in individuals 
without pre-existing cardiovascular disease, reporting greatest effects with systolic blood pressure and 
body mass index. Building on these observations, Jensen et al.28 present novel insights into diabetic 
cardiomyopathy, demonstrating subclinical remodelling of all four cardiac chambers in diabetics 
without known cardiovascular disease. In a study assessing the causality of previously established 
associations between increased systolic blood pressure and adverse LV remodelling, Hendriks et al.29 
use the genetic data in UKB to demonstrate a novel line of evidence supporting a causal relationship 
between elevated systolic blood pressure and higher LV mass. Linkage with the genetic data has also 
enabled discovery of 14 genetic loci corresponding to prognostically important LV phenotypes 
including end-diastolic and end-systolic volumes, mass, and ejection fraction, enhancing 
understanding of the genetic architecture of cardiac phenotypes and providing insights into potential 
novel therapeutic targets30. 
 
Investigating non-classical cardiovascular risk factors 
The scale of UKB and detailed characterisation of participants has enabled assessment of the effects 
of non-classical cardiovascular risk factors on CMR phenotypes, providing insights into novel 
determinants of cardiovascular disease. In a study of 1,406 individuals without cardio-respiratory 
disease, Thomson et al.31 report association of poorer respiratory function by spirometry with adverse 
ventricular remodelling. Somewhat linked to these observations, Aung et al.32 report association of 
adverse cardiac phenotypes with past exposure to poorer air quality in 3,920 individuals without 
clinical cardiovascular disease. Khanji et al.33 present the first study of cardiac phenotypes associated 
with recreational cannabis use, demonstrating larger LV volumes and impaired circumferential strain 
in regular cannabis users compared with never/rare users. Van Hout et al.34 consider the abdominal 
magnetic resonance images in UKB alongside the CMR data to investigate the relationship of body 
fat distribution with cardiac structure and function, demonstrating the importance of visceral obesity 
(vs. subcutaneous adiposity) and its association with smaller LV end-diastolic volumes and lower 
systolic cardiac function. In a study incorporating biochemistry, imaging, and clinical outcome data, 
Raisi-Estabragh et al.35 demonstrate association of poorer bone health with worse arterial health and 
adverse ischaemic cardiovascular outcomes and explore potential mediating mechanisms of these 
relationships. The UKB data has also been used to explore the association of cardiac health to other 
non-classical cardiovascular risk factors such as menopausal hormone therapy, spontaneous 
pregnancy loss, and resting heart rate36–38. 
 
Development of novel imaging biomarkers 
Several researchers have used the UKB CMR platform to investigate novel imaging biomarkers. 
Cardiac morphometric atlases are derived from existing CMR data and provide statistical shape 
models of the heart with highly detailed morphometric information39. LV cardiac atlas morphometrics 
have been associated with a number of important cardiovascular risk factors40. In the first study to 
compare cardiac atlases derived using different methodologies, Gilbert et al.41 use the UKB dataset to 
demonstrate robust associations between cardiac atlas shape measures and cardiovascular risk factors 
irrespective of methodology. Further, they demonstrate superior performance of cardiac atlas 
morphometric scores for detection of differences in LV shape associated with cardiovascular risk 
factors compared to conventional CMR shape indices. Building on this work, Mauger et al.42 used the 
UKB dataset to quantify reference RV morphometry and demonstrate complex relationships between 
biventricular shape and cardiovascular risk factors (Figure 2).  
 
CMR radiomics is another novel image analysis technique whereby voxel-level information is used to 
derive multiple quantifiers of shape and texture (Figure 3)43. There is no requirement for dedicated 
acquisitions or post-processing and radiomics analysis may be retrospectively applied to existing 
CMR images. Machine learning techniques are often used to incorporate the many extracted 
radiomics features (usually 100s) as covariates into clinical prediction models. CMR radiomics 
models have demonstrated incremental diagnostic and predictive value in comparison to conventional 
methods for a number of important cardiovascular conditions43. Cetin et al.44 have used data from the 
UKB to demonstrate the superior performance of CMR radiomics models, compared to conventional 
CMR indices, in discriminating individuals with hypertension from healthy comparators. 
 
Artificial intelligence technologies for automated image analysis 
The large volume of data in the UKB image bank necessitates the development of automated image 
analysis pipelines that are scalable, require minimal manual interaction, and have standardised quality 
control measures. The 5,000 reference cohort and their corresponding contours have enabled 
development and evaluation of machine learning methods for cardiac chamber segmentation with 
some promising results45. In particular, Attar et al.46 present a fully automatic pipeline performing 
end-to-end analytics from cine images to anatomic and functional quantification (LV, RV) on 20,000 
UKB CMR scans validated against the ground truth cohort of manual segmentations. A fully 
automated image analysis tool for measurement of aortic distensibility has also been developed and 
validated on a large subset of UKB studies (n=5,100); the analysis pipeline can detect and locate 
aortic areas and has in-built quality control mechanisms47. 
 
In addition to these purpose-built pipelines, fully automated LV quantification is performed as part of 
UKB image acquisitions using the Siemens syngo InlineVF software (Siemens Healthcare, Erlangen, 
Germany, version D13A). The InlineVF analysis algorithm determines the LV endocardial contours 
on the short axis slices, defines the LV base (mitral valve) and apex on long axis slices, and outputs 
standard LV indices (volumes, ejection fraction, stroke volume). Whilst raw results from this analysis 
are provided by the UKB, the InlineVF software is intended for use in clinical settings with expert 
assessment of contour quality. Therefore, it is advisable to apply quality control measures to the fully 
automated outputs of UKB. After formal evaluation of the InlineVF outputs, we recommend that 
these be used with implementation of visual assessment for quality control and linear bias 
correction48. 
 
Potential for future work 
In order to best utilise the UKB, we must consider the resource in its entirety and appreciate the 
complementary value of its different components. The scale and extensive participant phenotyping in 
UKB permits consideration of a large number of exposures and their potential interactions with many 
disease conditions. These research opportunities will increase as incident disease outcomes accrue and 
the imaging study is completed. The breadth, depth, and scale of phenotypic information in UKB also 
yields unique opportunities to investigate relationships of risk factors acting across organ systems. 
There is increasing interest in exploration of cross-system interactions with notable work exploring 
the heart-brain49 and heart-gut50 axes. Already, researchers have demonstrated links between 
cognition and structural brain MRI features and cardiac health in the UKB51. As disease outcomes 
accrue within the UKB cohort, there will be greater opportunity to explore these important cross-
system interactions. 
 
The large standardised UKB imaging datset provides an ideal platform for development and 
evaluation of automated image analysis pipelines. Artificial intelligence technologies for high volume 
image phenotype extraction could translate readily to clinical settings, improving time and resource 
efficiency. Substantial progress has been made with automated extraction of conventional ventricular 
indices and aortic distensibility in the UKB. Similar work is underway to develop scalable automated 
processes for analysis of tagging, native T1 mapping, tissue tracking, and aortic flow sequences. 
These areas have not yet been published on and are ripe for exploration. The dataset is also the ideal 
setting for development of novel CMR biomarkers. In addition to providing a platform for technical 
development, linkage to participant characteristics and outcomes uniquely enables assessment of 
clinical utility within the same sample. 
 
Conclusions 
The UKB presents the opportunity to examine prospectively, in a single, robustly powered and 
characterised cohort, a wide range of exposure-outcome relationships and the potential interactions 
between them. As incident health outcomes accrue, and the imaging study is completed, UKB will 
offer huge opportunities to undertake highly powered studies to comprehensively investigate the 
determinants of cardiovascular disease. It is now up to the imagination and expertise of researchers to 
translate this unique resource into real benefits for our patients and thus reduce the burden of 
cardiovascular disease worldwide. 
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Table 1. Estimated number of years from baseline to accrue cases of selected conditions in UK 
Biobank* 
 
Table 1 caption: COPD: chronic obstructive pulmonary disease; MI: myocardial infarction. 
*Estimated years from start of recruitment in 2006 with allowance for healthy cohort effect, overseas 
migration and comprehensive withdrawal of 1 in 500 participants. Adapted from: UK Biobank: 











 Time to achieve 
 1,000 cases 2,500 cases 5,000 cases 10,000 cases 20,000 cases 
MI and coronary death 2 years 4 years 5 years 8 years 13 years 
Stroke 5 years 8 years 12 years 18 years 28 years 
Diabetes mellitus 2 years 3 years 4 years 6 years 10 years 
COPD 4 years 6 years 8 years 13 years 23 years 
Colorectal cancer 5 years 9 years 14 years 22 years 42 years 
Hip fracture 7 years 11 years 15 years 21 years 31 years 
Alzheimer’s disease 7 years 10 years 13 years 18 years 23 years 
Parkinson’s disease 6 years 10 years 15 years 23 years 37 years 
 Table 2. Summary of UK Biobank cardiac magnetic resonance imaging protocol 
 
Table 2 footnote: AF: atrial fibrillation; bSSFP: balanced steady state free precession; GRE: gradient echo; HLA: horizontal long axis; LV: left ventricle; 
LVOT: left ventricular outflow tract; m/s: meters/second; RV: right ventricle; ShMOLLI: Shortened Modified Look-Locker Inversion recovery; VENC: 
velocity encoding; VLA: vertical long axis. 
 
 Sequence Imaging planes Related CMR indices Clinical utility 
Anatomic assessment Bright blood, bSSFP Sagittal, coronal, and transverse slices 
covering the chest and abdomen 
Modified anatomic measures e.g. 
aortic dimensions, lung diameters 
Markers of aortic/pulmonary disease 
Cardiac function bSSFP cine HLA, VLA, LVOT (sagittal, coronal), 
short axis stack covering the right and 
left ventricles 
RV/LV: volumes, ejection 
fraction, stroke volume; LV mass 
Conventional markers of cardiac 
remodelling and function with established 
prognostic significance.  
Atrial size and function Predictors of AF in the general population 
LV strain (tissue tracking) Early marker of myocardial dysfunction 
Tagging Strain CMR (GRE) Three short axis slices (base, mid, 
apex) 
LV strain (tissue tagging)  Early marker of myocardial dysfunction 
Thoracic aorta bSSFP cine Transverse cut at the level of the 
pulmonary trunk and right pulmonary 
artery 
Aortic distensibility at the 
ascending and descending aorta 
Markers of cardiovascular risk, in particular 
ischaemic disease 
Aortic flow Phase contrast flow 
(GRE), VENC set at 
2m/s with upward 
adjustment as needed 
Cut plane placed at or just above the 
sinotubular junction at end-diastole in 
LVOT views (sagittal, coronal) 
Aortic flow Aortic valve anatomy and assessment of 
aortic stenosis 
Native T1 mapping ShMOLLI 
(WIP780B) 
Mid-ventricular short axis Native T1 values  Indicator of myocardial fibrosis/infarction- 
markers of cardiovascular disease and risk.  
Figure legends  
 
Figure 1: No legend required.  
 
Figure 2: Adapted from Mauger et al. 201942. Panel A: hypertension; Panel B: no hypertension; 
models in end-diastole (left) and end-systole (right); the colours denote displacements from the mean 
in mm. Blue - inwards 3mm; red -outwards 3mm. 
 
Figure 3: Radiomics features may be extracted from a defined region of interest. In this example, the 
left (orange) and right (green) ventricular endocardial and left ventricular epicardial (blue) contours 
are drawn in end-systole on the short axis stack cine images. Thus, defining three regions of interest: 
left ventricular blood pool, right ventricular blood pool, and left ventricular myocardium. Radiomics 
shape features are extracted from a 3D image mask constructed from these contours. Histogram based 
first-order features and more complex texture features are derived from analysis of the distribution 
and pattern of voxel signal intensities in the defined regions of interest. Figure courtesy of: Dr. 
Polyxeni Gkontra and Prof. Karim Lekadir, University of Barcelona.  
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Figure 2. Cardiac atlas models demonstrating morphometric differences in UK Biobank 













*Figure 2 caption: Adapted from Mauger et al. 201939. Panel A: hypertension; Panel B: no 
hypertension; models in end-diastole (left) and end-systole (right); the colours denote displacements 














*Figure 3 caption: Radiomics features may be extracted from a defined region of interest. In this example, the left (orange) and right (green) ventricular 
endocardial and left ventricular epicardial (blue) contours are drawn in end-systole on the short axis stack cine images. Thus, defining three regions of 
interest: left ventricular blood pool, right ventricular blood pool, and left ventricular myocardium. Radiomics shape features are extracted from a 3D image 
mask constructed from these contours. Histogram based first-order features and more complex texture features are derived from analysis of the distribution 
and pattern of voxel signal intensities in the defined regions of interest. Figure courtesy of: Dr. Polyxeni Gkontra and Prof. Karim Lekadir, University of 




Supplementary Table 1. Summary of selected studies using UK Biobank CMR data 
 
Author, year of 
publication 
Research question/aim Methods Summary of findings 
Raisi-Estabragh et 
al. 2020 
What is the association of 
speed of sound from 
quantitative heel ultrasound 
with measures of arterial 
stiffness (AoD, ASI) and 
with ischaemic 
cardiovascular outcomes 
and what are the mediating 
factors? 
Mutivariable linear regression models of the association 
between speed of sound and ASI/AoD. Cox/competing 
risk regression models to test association of speed of sound 
with incident myocardial infarction and ischaemic heart 
disease death. Subanalysis by sex and menopause status. 
Multiple mediation analysis to examine mediating effect of 
a range of biochemical variables.  
Findings support a positive association between 
bone and vascular health with consistent patterns 
of association in men and women. The underlying 
mechanisms are complex and appear to vary by 
sex. 
Hout et al. 2020 What is the association of 
body fat distribution with 
cardiovascular structure and 
function? 
 Multivariable regression models were used to test the 
association of subcutaneous adiposity, visceral adiposity 
and body fat percentage with CMR cardiovascular 
phenotypes in 4,590 UKB participants. 
Visceral obesity was associated with a smaller LV 
EDV and subclinical lower LV systolic function 
in men, suggesting that visceral obesity might 
play a more important role compared to general 
obesity in LV remodelling. 
Supplementary Table 1
Biasiolli et al. 2019 To develop and validate a 
fully automated method to 
detect and localise the 
ascending and descending 
aorta for AoD measure with 
a quality control 
mechanism. 
The automated AA and PDA detection-localization 
algorithm followed these steps: 1) foreground 
segmentation; 2) detection of candidate ROIs by Circular 
Hough Transform; 3) spatial, histogram and shape feature 
extraction for candidate ROIs; 4) AA and PDA detection 
using Random Forest (RF); 5) quality control based on RF 
detection probability. The algorithm was tested on 3,900 
UKB CMR scans. 
The proposed method for automated AA and PDA 
localization was extremely accurate and the 
automatically derived detection probabilities 
provided a robust mechanism to detect low quality 
scans for further human review. 
Attar et al. 2019 To develop and evaluate a 
fully automated CMR 
image analysis pipeline.  
The authors present and evaluate a fully automatic scalable 
CMR  image analysis pipeline with inbuilt quality control 
using 20,000 cases from the UKB for LV/RV 
quantification. The pipeline is validated on 4,620 manually 
annotated UKB cases.  
The presented pipeline performs end-to-end image 
analytics from multi-view cine CMR to LV/RV 
quantification without need for manual user 
interactions, with quality control of image input 
and outputted segmentations. 
Jensen et al. 2019 What are the early 
alterations in cardiac 
structure and function 
associated with DM? 
Multivariable regression models were built to ascertain the 
association of DM status with CMR phenotypes in a 
subpopulation without pre-existing cardiovascular disease 
and LVEF ≥ 50% (n=3984) 
In a low-risk general population without known 
cardiovascular disease and with preserved LV 
ejection fraction, DM was associated with early 
changes in all 4 cardiac chambers.  
Hendriks et al. 2019 What are the effects of 
lifelong exposure to high 
SBP on LV structure and 
function? 
A genetic risk score to estimate genetically predicted SBP 
(gSBP) was constructed based on 107 previously 
established genetic variants. Manual CMR image analysis 
was performed for 300 individuals at the extremes of 
gSBP. Multivariable linear regression analyses of imaging 
biomarkers were performed using gSBP as continuous 
independent variable. 
This study provides a novel line of evidence for a 
causal relationship between SBP and increased 
LV mass and with increased LV global radial 
strain. 
Aung et al. 2019 What is the genetic basis of 
LV image-derived 
phenotypes? 
Genome wide association study of LVEDV, LVESV, 
LVEF, and LVM, using 16,923 CMR cases from the UK 
Biobank and genotyping data at baseline. 
14 novel genetic loci were identified for LV CMR 
phenotypes. 
Khanji et al. 2019 What is the association of 
cannabis use with 
cardiovascular structure and 
function on CMR? 
Multivariate regression models were used to test effect of 
regular, never/rare, or previous cannabis use on CMR 
cardiovascular indices in a sample of 3,407 UKB 
participants. 
Regular cannabis use was associated with larger 
LVEDV, LVESV, and impaired global 
circumferential strain compared with rare/no 
cannabis use. 
Elmahi et al. 2019 What is the association 
between history of 
pregnancy loss and imaging 
Multivariable linear regression models were used to test 
association between self-reported pregnancy loss and 
CMR measures of cardiac structure and function and 
In this analysis, women who self-report pregnancy 
loss did not have significant differences in cardiac 
measures of cardiovascular 
function? 
carotid ultrasound measures of arterial health in 2660 
women from UKB. 
structure, cardiac function, or carotid structure in 
later life. 
Gilbert et al. 2019 What are the associations of 
cardiac atlas morphometric 
measures with 
cardiovascular risk factors 
and do these vary by type of 
atlas? 
Two independent LV atlases were constructed from 4,547 
UKB CMR scans. The strength of associations between 
atlas principal components and cardiovascular risk factors 
(smoking, DM , high blood pressure, high cholesterol and 
angina) were quantified with logistic regression models. 
Comparison was made between different atlases. 
Morphometric variations associated with each risk 
factor could be quantified and visualized and were 
similar between atlases. UK Biobank LV shape 
atlases are robust to construction method and 
show stronger relationships with cardiovascular 
risk factors than mass and volume. 
Mauger et al. 2019 What are the associations 
between cardiovascular 
disease risk factors and the 
biventricular cardiac atlas 
morphometrics?   
A biventricular shape atlas was automatically constructed 
using contours and landmarks from 4,329 UKB CMR 
studies. A reference sub-cohort was identified consisting 
of 630 participants with no cardiovascular risk factors. 
Morphometric scores were computed using linear 
regression to quantify shape variations associated with 
high cholesterol, high blood pressure, obesity, smoking, 
DM, previous myocardial infarction and angina. 
Morphometric relationships between biventricular 
shape and cardiovascular risk factors in a large 
cohort show complex interactions between RV 
and LV morphology. These can be quantified by 
z-scores, which can be used to study the 
morphological correlates of disease. 
Bai et al. 2018 To develop automated 
methods for CMR cardiac 
chamber segmentation? 
Aa fully convolutional network was trained and evaluated 
on a 4,875 CMR studies from the UK Biobank to develop 
a fully an automated analysis method for segmentation of 
LV, RV, LA, and RA. 
The presented automated method achieves a 
performance on par with human experts in 
analysing CMR images and deriving clinically 
relevant measures. 
Sanghvi et al. 2018 What is the effect of 
menopausal hormonal 
therapy on CMR 
cardiovascular phenotypes? 
Multivariable linear regression was performed to examine 
the relationship between CMR cardiac parameters and 
menopausal hormonal therapy use ≥ 3 years in 1,604 
postmenopausal women from UKB. 
Menopausal hormonal therapy use was not 
associated with adverse, subclinical changes in 
cardiac structure and function 
Aung et al. 2018 What is the effect of 
exposure to ambient air 
pollution on CMR 
cardiovascular phenotypes? 
Multivariable linear models were built to test association 
of previous exposure to ambient air pollution on CMR 
indices of cardiac structure and function in 3,920 UKB 
participants without pre-existing cardiovascular disease. 
Higher past exposure to particulate matter with an 
aerodynamic diameter <2.5 µm and nitrogen 
dioxide was associated with cardiac ventricular 
dilatation, a marker of adverse remodelling. 
Thomson et al. 2018 What is the relationship 
between lung function and 
CMR cardiovascular 
phenotypes in individuals 
without respiratory disease? 
Multivariable linear models were built to test association 
of spirometry measures of lung function (obtained at 
baseline UKB visit) with CMR indices of cardiac structure 
and function in individuals without respiratory disease 
(n=1,406) 
This study shows that reduced FEV1 and FVC are 
associated with smaller ventricular vol- umes and 
reduced ventricular mass. The changes seen per 
standard deviation change in FEV1 and FVC are 
comparable to one decade of ageing. 
Petersen et al. 2017 What is the impact of 
classical cardiovascular risk 
factors on cardiac CMR 
phenotypes? 
 
Multivariable regression models were built to ascertain the 
association of risk factors (Age, sex, ethnicity, SBP, DBP, 
smoking status, exercise, BMI, high cholesterol, DM, 
alcohol intake) on LV, RV, LA and RA CMR parameters 
in 4,651 UKB participants. 
Modifiable risk factors are associated with 
subclinical alterations in structure and function in 
all four cardiac chambers. BMI and SBP were the 
most important factors affecting CMR parameters 
known to be linked to adverse outcomes. 
 
Supplementary Table 1 caption: AA: ascending aorta; AoD: aortic distensibility; ASI: arterial stiffness index; BMI: body mass index; CMR: cardiovascular 
magnetic resonance; DM: diabetes mellitus; EDV: end-diastolic volume; FEV1: forced expiratory volume 1; FVC: forced vital capacity; LA: left atrium; LV: 
left ventricle; LVEF: left ventricular ejection fraction; LVM: left ventricular mass; PDA: proximal descending aorta; RA: right atrium; ROI: region of 
interest; RV: right ventricle; SBP: systolic blood pressure; UKB: UK Biobank 
